Woodline Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Woodline Partners’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-140,700	Closed	-$5.54M	–	804
2023 Q2	$5.54M	Sell	140,700 -148,758	-51%	-$5.25M	0.07%	274
2023 Q1	$7.04M	Buy	+289,458	New	+$6.34M	0.1%	243
2022 Q4	–	Sell	-252,815	Closed	-$4.54M	–	902
2022 Q3	$4.54M	Buy	+252,815	New	+$3.32M	0.06%	313

Woodline Partners's ISEE Position: Q3 2023 in Review

Woodline Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 140,700 shares — an estimated $5.54M sold.

Woodline Partners first reported a position in ISEE in Q3 2022 and held it in 3 quarters. The position peaked at $7.04M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Woodline Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Woodline Partners sold 140,700 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $5.54M.
Woodline Partners first reported a position in IVERIC bio, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
Woodline Partners's IVERIC bio, Inc. Common Stock position peaked at $7.04M in Q1 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Woodline Partners's 13F filing for Q3 2023, filed 14 Nov 2023.